why choose us

First received: June 06, 2024

Clinical Trial: A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Venous Thromboembolism

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Multicenter, Randomized, Open-Label, Active Control Study of REGN7508, a Factor XI Monoclonal Antibody, for Prevention of Venous Thromboembolism After Elective, Unilateral, Total Knee Arthr

Brief Summary: This study is researching an experimental drug called REGN7508 (called "study drug").The study is focused on adults undergoing elective, unilateral (one side) total knee replacement (TKR) surgery.The aim of the study is to see how effective the study drug is at preventing venous thromboembolism (VTE) and other related diseases after unilateral total knee replacement surgery.The study is looking at several other research questions, including:What side effects may happen from taking the study drugHow much…

Read more